Circular RNA circ_0000228 promotes the malignancy of cervical cancer via microRNA-195-5p/ lysyl oxidase-like protein 2 axis

References

• Melamed A, Margul DJ, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379:1905–1914.
   PubMed Web of Science ®Google Scholar
• Simms KT, Hanley S, Smith MA, et al. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modeling study. Lancet Public Health. 2020;5:e223–e234.
   PubMed Web of Science ®Google Scholar
• Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019;71:313–320.
   PubMed Web of Science ®Google Scholar
• Rajappa A, Banerjee S, Sharma V, et al. Circular RNAs: emerging role in cancer diagnostics and therapeutics. Front Mol Biosci. 2020;7:577938.
   PubMed Web of Science ®Google Scholar
• Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. CELL. 2019;176:869–881.
   PubMed Web of Science ®Google Scholar
• He S, Yu G, Peng K, et al. MicroRNA-145-5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells. Mol Med Rep. 2020;22:5282–5292.
   PubMed Web of Science ®Google Scholar
• Ding Z, Liu SJ, Liu XW, et al. MiR-16 inhibits proliferation of cervical cancer cells by regulating KRAS. Eur Rev Med Pharmacol Sci. 2020;24:10419–10425.
   PubMedGoogle Scholar
• Yu S, Zhao N, He M, et al. MiRNA-214 promotes the pyroptosis and inhibits the proliferation of cervical cancer cells via regulating the expression of NLRP3. Cell Mol Biol (Noisy-le-grand). 2020;66:59–64.
   Web of Science ®Google Scholar
• Liu X, Zhou Y, Ning YE, et al. MiR-195-5p inhibits malignant progression of cervical cancer by targeting YAP1. Onco Targets Ther. 2020;13:931–944.
   PubMed Web of Science ®Google Scholar
• Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998;16:387–398.
   PubMed Web of Science ®Google Scholar
• Tian J, Sun HX, Li YC, et al. LOXL 2 promotes the epithelial-mesenchymal transition and malignant progression of cervical cancer. Onco Targets Ther. 2019;12:8947–8954.
   PubMedGoogle Scholar
• Li P, Lv H, Xu M, et al. ARHGAP6 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through STAT3 signaling pathway. Cancer Manag Res. 2020 Oct 6;12:9665–9678.
   PubMed Web of Science ®Google Scholar
• Xie J, Chen Q, Zhou P, et al. Circular RNA hsa_circ_0000511 improves epithelial mesenchymal transition of cervical cancer by regulating hsa-mir-296-5p/HMGA1. J Immunol Res. 2021 May 27;2021:9964538.
   PubMed Web of Science ®Google Scholar
• Chen S, Huang L, Li G, et al. LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression. Clin Epigenetics. 2020 Nov 7;12(1):168.
   PubMed Web of Science ®Google Scholar
• Zhou L, Xu XL. Long non-coding RNA ARAP1-AS1 facilitates the progression of cervical cancer by regulating miR-149-3p and POU2F2. Pathobiology. 2021 May;7:1–12.
   Google Scholar
• Li Y, Tang Y, Li Z, et al. CircSOS2 promotes cervical squamous cell carcinoma by regulation of proliferation, cell cycle, apoptosis, migration, invasion, and glycolysis by targeting miR-543/FNDC3B axis. Arch Biochem Biophys. 2021 May 21;708:108925.
   PubMed Web of Science ®Google Scholar
• Granados-López AJ, Manzanares-Acuña E, López-Hernández Y, et al. UVB inhibits proliferation, cell cycle and induces apoptosis via p53, E2F1 and microtubules system in cervical cancer cell lines. Int J Mol Sci. 2021 May 14;22(10):5197.
   PubMed Web of Science ®Google Scholar
• Chaichian S, Shafabakhsh R, Mirhashemi SM, et al. Circular RNAs: a novel biomarker for cervical cancer. J Cell Physiol. 2020;235:718–724.
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen Z, Sun J, et al. CircRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis. Cancer Cell Int. 2020;20:287.
   PubMedGoogle Scholar
• Chen R, Mao L, Shi R, et al. circRNA MYLK accelerates cervical cancer via up-regulation of RHEB and activation of mTOR signaling. Cancer Manag Res. 2020;12:3611–3621.
   PubMed Web of Science ®Google Scholar
• Ou R, Mo L, Tang H, et al. circRNA-AKT1 sequesters miR-942-5p to upregulate AKT1 and promote cervical cancer progression. Mol Ther Nucleic Acids. 2020;20:308–322.
   PubMedGoogle Scholar
• Gu Q, Hou W, Shi L, et al. Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression. Bioengineered. 2021 Dec;12(1):927–936.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344–352.
   PubMed Web of Science ®Google Scholar
• Cai C, He H, Duan X, et al. miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression. Oncol Rep. 2018 Apr;39(4):1658–1670.
   PubMed Web of Science ®Google Scholar
• Wan T, Zheng J, Yao R, et al. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway. Ann Hepatol. 2021;20:100258.
   Web of Science ®Google Scholar
• Kong L, Zhang C. LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p. Cancer Cell Int. 2020;20:370.
   PubMed Web of Science ®Google Scholar
• Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer. 2012;12:540–552.
   PubMed Web of Science ®Google Scholar
• Yang J, Savvatis K, Kang JS, et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun. 2016;7:13710.
   PubMed Web of Science ®Google Scholar
• Ikenaga N, Peng ZW, Vaid KA, et al. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. GUT. 2017;66:1697–1708.
   PubMed Web of Science ®Google Scholar
• Fong SF, Dietzsch E, Fong KS, et al. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes Chromosomes Cancer. 2007;46:644–655.
   PubMed Web of Science ®Google Scholar
• Peng L, Ran YL, Hu H, et al. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis. 2009;30:1660–1669.
   PubMed Web of Science ®Google Scholar
• Baker AM, Bird D, Welti JC, et al. Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res. 2013;73:583–594.
   PubMed Web of Science ®Google Scholar